Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy

International Journal of Stroke

Volumn 11, Issue 9, 2016, Pages 1036-1044

  Ahn, Seong Hwan ^a   Hong, Ran ^a   Choo, In Sung ^a   Heo, Ji Hoe ^b   Nam, Hyo Suk ^b   Kang, Hyun Goo ^a   Kim, Hoo Won ^a   Kim, Jin Ho ^a  

^a Chosun University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

etiology; histology; Ischemic stroke; stroke subtype; thrombectomy; thrombus

Indexed keywords

ALTEPLASE; FIBRIN; UROKINASE; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ERYTHROCYTE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MECHANICAL THROMBECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION CATHETER; STROKE PATIENT; THROMBECTOMY DEVICE; THROMBOCYTE; THROMBOSIS; THROMBUS; CEREBRAL REVASCULARIZATION; COMPARATIVE STUDY; METABOLISM; PATHOLOGY; REPERFUSION; STROKE;

AGED; BLOOD PLATELETS; CEREBRAL REVASCULARIZATION; ERYTHROCYTES; FEMALE; FIBRIN; HUMANS; MALE; MECHANICAL THROMBOLYSIS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; REPERFUSION; STROKE; THROMBOSIS;

EID: 84995906485     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1177/1747493016641965     Document Type: Article

References (28)

1. Caplan LR. Antiplatelet therapy in stroke prevention: present and future. Cerebrovasc Dis 2006; 21(Suppl 1): 1–6.
2. Tan KT, Lip GY. Red vs. white thrombi: treating the right clot is crucial. Arch Intern Med 2003; 163: 2534–2535.
3. Marder VJ, Chute DJ, Starkman S. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006; 37: 2086–2093.
4. Simons N, Mitchell P, Dowling R, Gonzales M, Yan B. Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval. J Neuroradiol 2015; 42: 86–92.
5. Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS. Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 2015; 36: 1756–1762.
6. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28: 2119–2125.
7. Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC. Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 2003; 61: 71–75.
8. Hacke W, Kaste M, Bluhmki E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317–1329.
9. Higashida RT, Furlan AJ, Roberts H. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34: e109–e137.
10. Adams HP Jr, Bendixen BH, Kappelle LJ. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
11. Aarts PA, van den Broek SA, Prins GW, Kuiken GD, Sixma JJ, Heethaar RM. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis 1988; 8: 819–824.
12. Nesbitt WS, Westein E, Tovar-Lopez FJ. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15: 665–673.
13. Jackson SP. Arterial thrombosis – insidious, unpredictable and deadly. Nat Med 2011; 17: 1423–1436.
14. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009; 373: 155–166.
15. Kamath S, Blann AD, Lip GY. Platelets and atrial fibrillation. Eur Heart J 2001; 22: 2233–2242.
16. Lim HS, Willoughby SR, Schultz C. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol 2013; 61: 852–860.
17. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005; 129: 307–321.
18. Lord ST. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol 2011; 31: 494–499.
19. Bivard A, Lin L, Parsonsb MW. Review of stroke thrombolytics. J Stroke 2013; 15: 90–98.
20. Loren M, Garcia Frade LJ, Torrado MC, Navarro JL. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res 1989; 56: 67–75.
21. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99: 3050–3055.
22. Boulaftali Y, Ho-Tin-Noe B, Pena A. Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation 2011; 123: 1326–1334.
23. Wohner N, Sotonyi P, Machovich R. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31: 2306–2313.
24. Urbach H, Hartmann A, Pohl C. Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology 2002; 44: 695–699.
25. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004; 35: 486–490.
26. Nam HS, Lee KY, Kim YD. Failure of complete recanalization is associated with poor outcome after cardioembolic stroke. Eur J Neurol 2011; 18: 1171–1178.
27. Sanna T, Diener HC, Passman RS. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478–2486.
28. Hart RG, Diener HC, Coutts SB. Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol 2014; 13: 429–438.